|
1
|
Steller H: Mechanisms and genes of
cellular suicide. Science. 267:1445–1449. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hickman JA: Apoptosis induced by
anticancer drugs. Cancer Metastasis Rev. 11:121–139. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang JY: Apoptosis-based anticancer
drugs. Nat Rev Drug Discov. 1:101–102. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
MacFarlane M: TRAIL-induced signalling and
apoptosis. Toxicol Lett. 139:89–97. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lieu PT, Heiskala M, Peterson PA and Yang
Y: The roles of iron in health and disease. Mol Aspects Med.
22:1–87. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Toyokuni S: Iron-induced carcinogenesis:
the role of redox regulation. Free Radic Biol Med. 20:553–566.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nelson RL: Dietary iron and colorectal
cancer risk. Free Radic Biol Med. 12:161–168. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bedford MR, Ford SJ, Horniblow RD, Iqbal
TH and Tselepis C: Iron chelation in the treatment of cancer: a new
role for deferasirox? J Clin Pharmacol. 53:885–891. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nurtjahja-Tjendraputra E, Fu D, Phang JM
and Richardson DR: Iron chelation regulates cyclin D1 expression
via the proteasome: a link to iron deficiency-mediated growth
suppression. Blood. 109:4045–4054. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fu D and Richardson DR: Iron chelation and
regulation of the cell cycle: 2 mechanisms of posttranscriptional
regulation of the universal cyclin-dependent kinase inhibitor
p21CIP1/WAF1 by iron depletion. Blood. 110:752–761.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hershko C: Control of disease by selective
iron depletion: a novel therapeutic strategy utilizing iron
chelators. Baillieres Clin Haematol. 7:965–1000. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Olivieri NF and Brittenham GM:
Iron-chelating therapy and the treatment of thalassemia. Blood.
89:739–761. 1997.PubMed/NCBI
|
|
13
|
Yun Z, Maecker HL, Johnson RS and Giaccia
AJ: Inhibition of PPARγ2 gene expression by the HIF-1-regulated
gene DEC1/Stra13: a mechanism for regulation of adipogenesis by
hypoxia. Dev Cell. 2:331–341. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakayama K: Cellular signal transduction
of the hypoxia response. J Biochem. 146:757–765. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Deter RL and De Duve C: Influence of
glucagon, an inducer of cellular autophagy, on some physical
properties of rat liver lysosomes. J Cell Biol. 33:437–449. 1967.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boya P, González-Polo RA, Casares N, et
al: Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol.
25:1025–1040. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Karantza-Wadsworth V, Patel S, Kravchuk O,
et al: Autophagy mitigates metabolic stress and genome damage in
mammary tumorigenesis. Genes Dev. 21:1621–1635. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Degenhardt K, Mathew R, Beaudoin B, et al:
Autophagy promotes tumor cell survival and restricts necrosis,
inflammation, and tumorigenesis. Cancer Cell. 10:51–64. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lum JJ, Bauer DE, Kong M, et al: Growth
factor regulation of autophagy and cell survival in the absence of
apoptosis. Cell. 120:237–248. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu YL, DeLay M, Jahangiri A, et al:
Hypoxia-induced autophagy promotes tumor cell survival and
adaptation to antiangiogenic treatment in glioblastoma. Cancer Res.
72:1773–1783. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chaudhari AA, Seol JW, Lee YJ, Seol DW and
Park SY: Hypoxia protects articular chondrocytes from
thapsigargin-induced apoptosis. Biochem Biophys Res Commun.
381:513–517. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Agarwal E, Brattain MG and Chowdhury S:
Cell survival and metastasis regulation by Akt signaling in
colorectal cancer. Cell Signal. 25:1711–1719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Degterev A, Boyce M and Yuan J: A decade
of caspases. Oncogene. 22:8543–8567. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rubinsztein DC, Cuervo AM, Ravikumar B, et
al: In search of an ‘autophagomometer’. Autophagy. 5:585–589. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Matsumoto G, Wada K, Okuno M, Kurosawa M
and Nukina N: Serine 403 phosphorylation of p62/SQSTM1 regulates
selective autophagic clearance of ubiquitinated proteins. Mol Cell.
44:279–289. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kroemer G and Jäättelä M: Lysosomes and
autophagy in cell death control. Nat Rev Cancer. 5:886–897. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Y, Cui Y, Shi M, Zhang Q, Wang Q and
Chen X: Deferoxamine promotes MDA-MB-231 cell migration and
invasion through increased ROS-dependent HIF-1α accumulation. Cell
Physiol Biochem. 33:1036–1046. 2014. View Article : Google Scholar
|
|
30
|
Bertout JA, Patel SA and Simon MC: The
impact of O2 availability on human cancer. Nat Rev
Cancer. 8:967–975. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mazure NM and Pouysségur J: Atypical
BH3-domains of BNIP3 and BNIP3L lead to autophagy in hypoxia.
Autophagy. 5:868–869. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gustafsson AB and Gottlieb RA: Autophagy
in ischemic heart disease. Circ Res. 104:150–158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang K, Liu R, Li J, et al: Quercetin
induces protective autophagy in gastric cancer cells: involvement
of Akt-mTOR- and hypoxia-induced factor 1α-mediated signaling.
Autophagy. 7:966–978. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
White E and DiPaola RS: The double-edged
sword of autophagy modulation in cancer. Clin Cancer Res.
15:5308–5316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Glick D, Barth S and Macleod KF:
Autophagy: cellular and molecular mechanisms. J Pathol. 221:3–12.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mizushima N: Autophagy: process and
function. Genes Dev. 21:2861–2873. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mizushima N, Yoshimori T and Levine B:
Methods in mammalian autophagy research. Cell. 140:313–326. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Singh K, Sharma A, Mir MC, et al:
Autophagic flux determines cell death and survival in response to
Apo2L/TRAIL (dulanermin). Mol Cancer. 13:702014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Park KJ, Lee SH, Kim TI, et al: A human
scFv antibody against TRAIL receptor 2 induces autophagic cell
death in both TRAIL-sensitive and TRAIL-resistant cancer cells.
Cancer Res. 67:7327–7334. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ikeda Y, Tajima S, Yoshida S, et al:
Deferoxamine promotes angiogenesis via the activation of vascular
endothelial cell function. Atherosclerosis. 215:339–347. 2011.
View Article : Google Scholar : PubMed/NCBI
|
